JANX
NASDAQ · Biotechnology
Janux Therapeutics Inc
$13.83
+0.27 (+1.99%)
Analyst Consensus
Strong Buy
26
Analysts
High
Coverage
Price Target
Analyst Price Target
+255.0% upside
Low Target
$33.46
Average Target
$49.10
High Target
$61.24
Current Price
$13.83
Current
$13.83
$13.83
Target
$49.10
$49.10
$33.46
$49.10 avg
$61.24
Scenario Analysis
Bear Case
$33.46
141.9%
Low target
Base Case
$49.10
+255.0%
Avg target
Bull Case
$61.24
+342.8%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$35.34
-60.9% from high
52-Week Low
$12.12
+14.1% from low
Target vs 52W High
$49.10
+38.9% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 39 | 69% | $257.58 | +24.3% |
| AMGN | Hold | 42 | 50% | $190.87 | -46.1% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +162.3% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | -3.7% |
| REGN | Strong Buy | 36 | 75% | $76.80 | -89.8% |
| ALNY | Strong Buy | 36 | 78% | $102.31 | -68.9% |
| INSM | Strong Buy | 26 | 92% | $143.40 | -3.3% |
| NTRA | Strong Buy | 27 | 89% | $142.91 | -27.6% |